Chemotherapy-induced anemia in adults: incidence and treatment
JE Groopman, LM Itri - Journal of the National Cancer Institute, 1999 - academic.oup.com
Anemia is a common complication of myelosuppressive chemotherapy that results in a
decreased functional capacity and quality of life (QOL) for cancer patients. Severe anemia is …
decreased functional capacity and quality of life (QOL) for cancer patients. Severe anemia is …
New insights into small‐cell lung cancer development and therapy
Y Wang, S Zou, Z Zhao, P Liu, C Ke… - Cell Biology …, 2020 - Wiley Online Library
Small‐cell lung cancer (SCLC) accounts for approximately 15% of lung cancer cases;
however, it is characterized by easy relapse and low survival rate, leading to one of the most …
however, it is characterized by easy relapse and low survival rate, leading to one of the most …
Small cell lung cancer, version 2.2022, NCCN clinical practice guidelines in oncology
The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Small Cell Lung
Cancer (SCLC) provide recommended management for patients with SCLC, including …
Cancer (SCLC) provide recommended management for patients with SCLC, including …
Small cell lung cancer
Neuroendocrine tumors account for approximately 20% of lung cancers; most (≈ 15%) are
small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for …
small cell lung cancer (SCLC). These NCCN Clinical Practice Guidelines in Oncology for …
Small-cell lung cancer
DM Jackman, BE Johnson - The Lancet, 2005 - thelancet.com
Small-cell lung carcinoma is an aggressive form of lung cancer that is strongly associated
with cigarette smoking and has a tendency for early dissemination. Increasing evidence has …
with cigarette smoking and has a tendency for early dissemination. Increasing evidence has …
Staging small cell lung cancer: Veterans Administration Lung Study Group versus International Association for the Study of Lung Cancer—what limits limited disease?
P Micke, A Faldum, T Metz, KM Beeh, F Bittinger… - Lung cancer, 2002 - Elsevier
Small cell lung cancer (SCLC) is usually classified into a two-stage system, limited (LD) and
extensive disease (ED). However, the criteria for these two categories remain controversial …
extensive disease (ED). However, the criteria for these two categories remain controversial …
Lung cancer—where are we today? Current advances in staging and nonsurgical treatment
SG Spiro, JC Porter - American journal of respiratory and critical …, 2002 - atsjournals.org
Lung cancer remains the commonest cause of cancer death in both men and women in the
developed world, although mortality rates for men are dropping. Spiral computed …
developed world, although mortality rates for men are dropping. Spiral computed …
Twenty years of phase III trials for patients with extensive-stage small-cell lung cancer: perceptible progress
PURPOSE: All cooperative group studies performed in North America for patients with
extensive-stage small-cell lung cancer (SCLC) were evaluated to determine the pattern of …
extensive-stage small-cell lung cancer (SCLC) were evaluated to determine the pattern of …
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects
IK Demedts, KY Vermaelen… - European Respiratory …, 2010 - Eur Respiratory Soc
Small cell lung cancer (SCLC) is an aggressive lung tumour strongly associated with
cigarette smoking, with patients often presenting with metastatic disease at the time of …
cigarette smoking, with patients often presenting with metastatic disease at the time of …
Small cell lung cancer
GR Simon, H Wagner - Chest, 2003 - Elsevier
Among patients with lung cancers, the proportion of those with small cell lung cancer
(SCLC) has decreased over the last decade. SCLC is staged as limited-stage disease and …
(SCLC) has decreased over the last decade. SCLC is staged as limited-stage disease and …